The chondramides: Cytostatic agents from myxobacteria acting on the actin cytoskeleton

Journal of the National Cancer Institute

Volumn 90, Issue 20, 1998, Pages 1559-1563

  Sasse, Florenz ^a   Kunze, Brigitte ^a   Gronewold, Thomas M A ^a   Reichenbach, Hans ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CHONDRAMIDE A; CHONDRAMIDE B; CHONDRAMIDE C; CHONDRAMIDE D; CYCLODEPSIPEPTIDE; CYTOCHALASIN D; CYTOSTATIC AGENT; JASPAMIDE; TETRAZOLIUM; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CHONDROMYCES CROCATUS; CYTOSKELETON; FLUORESCENCE; HUMAN; HUMAN CELL; MYXOCOCCALES; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR GROWTH;

CHONDROMYCES CROCATUS; JASPIS;

EID: 0032556187     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.20.1559     Document Type: Article

References (17)

1. Kunze B, Jansen R, Sasse F, Hofle G, Reichenbach H. Chondramides A-D, new antifungal and cytostatic depsipeptides from Chondromyces crocatus (myxobacteria). Production, physico-chemical and biological properties. J Antibiot 1995;48:1262-6.
2. Jansen R, Kunze B, Reichenbach H, Hofle G. Chondramides A-D, new cytostatic and antifungal cyclodepsipeptides from Chondromyces crocatus (myxobacteria): isolation and structure elucidation. Liebigs Annalen 1996;285-90.
3. Crews P, Manes LV, Boehler M. Jasplakinolide, a cyclodepsipeptide from marine sponge, Jaspis sp. Tetrahedron Lett 1986;27:2797-800.
4. Zabriskie TM, Klocke JA, Ireland CM, Marcus AH, Molinski TF, Faulkner DJ, et al. Jaspamide, a modified peptide from Jaspis sponge, with insecticidal and antifungal activity. J Am Chem Soc 1986;108:3123-4.
5. Akee RK, Carter LK, McCloud TG, Colin PL, Newman DJ. Distribution and preparative isolation of jaspamide, a marine anticancer cyclic peptide. Presented at the 38th Annual Meeting of the American Society of Pharmacognosy, Iowa City (IA); 1997.
6. Bubb MR, Senderowicz AM, Sausville EA, Duncan KL, Korn ED. Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin. J Biol Chem 1994;269:14869-71.
7. Senderowicz AM, Kaur G, Sainz E, Laing C, Inman WD, Rodriguez J, et al. Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the cell skeleton. J Natl Cancer Inst 1995;87:46-51.
8. Pardee JD, Spudich JA. Purification of muscle actin. Methods Enzymol 1982;85 Pt. B:164-81.
9. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods 1983;65:55-63.
10. Gerth K, Bedorf N, Hofle G, Irschik H, Reichenbach H. Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (myxobacteria). Production, physicochemical and biological properties. J Antibiot 1996;49:560-3.
11. Hofle G, Bedorf N, Steinmetz H, Schomburg D, Gerth K, Reichenbach H. Epothilone A and B - Novel 16-membered macrolides with cytotoxic activity: isolation, crystal structure, and conformation in solution. Angew Chem Int Ed Engl 1996;35:1567-9.
12. Gronewold TM, Sasse F, Luensdorf H, Reichenbach H. The effects of rhizopodin and latrunculin B on the morphology and on the actin cystoskeleton of mammalian cells. Cell Tiss Res. In press 1998.
13. Carter SB. Effects of cytochalasins on mammalian cells. Nature 1967;213:261-4.
14. Rao KM, Padmanabhan J, Cohen HJ. Cytochalasins induce actin polymerization in human leukocytes. Cell Motil Cytoskeleton 1992;21:58-64.
15. Flanagan MD, Lin S. Cytochalasins block actin filament elongation by binding to high affinity sites associated with F-actin. J Biol Chem 1980;255:835-8.
16. Brenner SL, Korn ED. The effects of cytochalasins on actin polymerization and actin ATPase provide insights into the mechanism of polymerization. J Biol Chem 1980;255:841-4.
17. Fabian I, Shur I, Bleiberg I, Rudi A, Kashman Y, Lishner M. Growth modulation and differentiation of acute myeloid leukemia cells by jaspamide. Exp Hematol 1995;23:583-7.